Influenza virus vaccine, Attenuated live, Intranasal (quadrivalent) (MedImmune)

鼻喷四价减毒活流感病毒疫苗（MedImmune）

Report date: 2026/04/21 20:00:18

Base Information

Drug NameInfluenza virus vaccine, Attenuated live, Intranasal (quadrivalent) (MedImmune)
Drug Alias Name减毒活流感疫苗 - MedImmuneQ-LAIV Flu VacQ/LAIVQuadrivalent live attenuated influenza vaccineQ-LAIV Flu Vaccination +[10] 
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, HumanRespiratory Tract Infections
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2013/01/01
Country/TerritoryUnited StatesIsraelSpain +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStanford UniversityMedimmune LlcAstrazeneca Ab
Active IndicationsInfluenza, Human
Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeJ07BB03
Related LinksN/A